Talking about more revenue, the animal related product CPH are releasing 3rd qtr this year is going to be interesting. I feel it is currently underestimated on what the market demand will be, especially in the European and Northern American markets. People, human nature have a great emotional attachment to their pets and if treatment is proven to be successful in pain relief ,eating disorders etc as a natural alternative to other synthetic treatments that may have negative side effects then this product will be huge. One of the reasons I invested in CPH was because of this opportunity. Looking forward to the launch in a couple of months and the cash cow to be medicated and flowing.
CPH Price at posting:
62.5¢ Sentiment: Buy Disclosure: Held
